WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 1.3% of their position (2.50K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $2.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/16/2024ACC: 0001213900-24-109363
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+2.50K
Net shares
Net buyer
$2.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$0.84
Trade value
$2.10K
% of position
1.3%
12/13/2024
185.43K→187.93K
Total
Net shares
+2.50K
Net value
$2.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/13/2024 | P · Purchase | +2.50K | $0.84 | $2.10K | 1.3% | 185.43K | 187.93K |
| Total | +2.50K | $2.10K | ||||||
Derivative Transactions0
No derivative transactions reported